Tri Chemical Laboratories Inc. provided consolidated earnings guidance fiscal year ending January 31, 2023. For the year, the company expects net sales of JPY 13,600 million, operating profit of JPY 3,621 million, profit attributable to owners of parent JPY 5,193 million and basic earnings per share of JPY 159.82.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,310 JPY | +0.23% | -0.12% | +19.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.39% | 916M | |
+14.70% | 65.04B | |
-1.61% | 47.76B | |
+14.58% | 40.72B | |
+20.84% | 26.88B | |
+1.16% | 17.53B | |
-21.87% | 16.03B | |
+1.11% | 15.17B | |
-11.34% | 15.06B | |
-20.82% | 13.62B |
- Stock Market
- Equities
- 4369 Stock
- News Tri Chemical Laboratories Inc.
- Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending January 31, 2023